Lifeist Wellness Inc. (LFST.V)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 21.65 Million CAD | -1.85% |
| 2022 | 22.06 Million CAD | -3.29% |
| 2021 | 22.81 Million CAD | -9.1% |
| 2020 | 25.1 Million CAD | 53.64% |
| 2019 | 16.34 Million CAD | -11.97% |
| 2018 | 18.56 Million CAD | 69.02% |
| 2017 | 10.98 Million CAD | 214.75% |
| 2016 | 3.48 Million CAD | -23.63% |
| 2015 | 4.56 Million CAD | 1999.3% |
| 2014 | 217.6 Thousand CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 4.9 Million CAD | 3.7% |
| 2024 Q3 | 2.05 Million CAD | -47.26% |
| 2024 Q2 | 3.9 Million CAD | -20.41% |
| 2023 Q3 | 4.79 Million CAD | -23.08% |
| 2023 Q2 | 6.23 Million CAD | 5.47% |
| 2023 Q1 | 5.9 Million CAD | -5.21% |
| 2023 FY | 21.65 Million CAD | -1.85% |
| 2023 Q4 | 4.72 Million CAD | -1.42% |
| 2022 Q4 | 6.23 Million CAD | -8.79% |
| 2022 Q2 | 4.13 Million CAD | -24.08% |
| 2022 Q1 | 5.45 Million CAD | -12.67% |
| 2022 FY | 22.06 Million CAD | -3.29% |
| 2022 Q3 | 6.83 Million CAD | 65.18% |
| 2021 Q4 | 6.24 Million CAD | 7.84% |
| 2021 Q2 | 5.27 Million CAD | -4.33% |
| 2021 Q1 | 5.51 Million CAD | -23.26% |
| 2021 FY | 22.81 Million CAD | -9.1% |
| 2021 Q3 | 5.78 Million CAD | 9.7% |
| 2020 Q2 | 6.92 Million CAD | 30.51% |
| 2020 Q1 | 5.3 Million CAD | 34.46% |
| 2020 Q3 | 5.68 Million CAD | -17.92% |
| 2020 Q4 | 7.18 Million CAD | 26.41% |
| 2020 FY | 25.1 Million CAD | 53.64% |
| 2019 Q3 | 3.8 Million CAD | -4.72% |
| 2019 Q1 | 4.59 Million CAD | -15.03% |
| 2019 Q2 | 3.99 Million CAD | -13.05% |
| 2019 Q4 | 3.94 Million CAD | 3.72% |
| 2019 FY | 16.34 Million CAD | -11.97% |
| 2018 Q1 | 5.63 Million CAD | 14.25% |
| 2018 FY | 18.56 Million CAD | 69.02% |
| 2018 Q4 | 5.4 Million CAD | 37.42% |
| 2018 Q3 | 3.93 Million CAD | -3.15% |
| 2018 Q2 | 4.06 Million CAD | -27.9% |
| 2017 Q2 | 3.16 Million CAD | 65.92% |
| 2017 Q1 | 1.9 Million CAD | -8.63% |
| 2017 FY | 10.98 Million CAD | 214.75% |
| 2017 Q4 | 4.93 Million CAD | 26.57% |
| 2017 Q3 | 3.89 Million CAD | 23.12% |
| 2016 Q4 | 2.08 Million CAD | 137.98% |
| 2016 Q2 | 738.19 Thousand CAD | 5.71% |
| 2016 FY | 3.48 Million CAD | -23.63% |
| 2016 Q1 | 698.33 Thousand CAD | -40.58% |
| 2016 Q3 | 877.03 Thousand CAD | 18.81% |
| 2015 FY | 4.56 Million CAD | 1999.3% |
| 2015 Q4 | 1.17 Million CAD | 7.16% |
| 2015 Q3 | 1.09 Million CAD | 0.88% |
| 2015 Q2 | 1.08 Million CAD | -14.4% |
| 2015 Q1 | 1.27 Million CAD | 71219.31% |
| 2014 Q4 | 1781.00 CAD | 0.0% |
| 2014 FY | 217.6 Thousand CAD | 0.0% |
| 2014 Q3 | 1781.00 CAD | -99.17% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q2 | 215.82 Thousand CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 254.89 Thousand CAD | -8397.519% |
| CanadaBis Capital Inc. | 22.22 Million CAD | 2.532% |
| Decibel Cannabis Company Inc. | 115.95 Million CAD | 81.321% |
| Delivra Health Brands Inc. | 12.37 Million CAD | -74.987% |
| Entourage Health Corp. | 40.71 Million CAD | 46.799% |
| Cannara Biotech Inc. | 57.26 Million CAD | 62.173% |
| Medicure Inc. | 21.69 Million CAD | 0.157% |
| PharmaCielo Ltd. | 1.54 Million CAD | -1304.887% |
| Rubicon Organics Inc. | 40.11 Million CAD | 46.008% |
| BioSyent Inc. | 31.59 Million CAD | 31.435% |
| Voyageur Pharmaceuticals Ltd. | - CAD | -Infinity% |